Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4279360
Max Phase: Preclinical
Molecular Formula: C32H24N4O3
Molecular Weight: 512.57
Molecule Type: Small molecule
Associated Items:
ID: ALA4279360
Max Phase: Preclinical
Molecular Formula: C32H24N4O3
Molecular Weight: 512.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccccc1)c1nnn(CCn2c(-c3ccccc3)c(-c3ccccc3)oc2=O)c1-c1ccccc1
Standard InChI: InChI=1S/C32H24N4O3/c37-30(25-17-9-3-10-18-25)27-28(23-13-5-1-6-14-23)36(34-33-27)22-21-35-29(24-15-7-2-8-16-24)31(39-32(35)38)26-19-11-4-12-20-26/h1-20H,21-22H2
Standard InChI Key: GEOVKPYOTISRKC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 512.57 | Molecular Weight (Monoisotopic): 512.1848 | AlogP: 5.97 | #Rotatable Bonds: 8 |
Polar Surface Area: 82.92 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.08 | CX LogD: 6.08 |
Aromatic Rings: 6 | Heavy Atoms: 39 | QED Weighted: 0.23 | Np Likeness Score: -0.70 |
1. Ramírez-Villalva A, González-Calderón D, Rojas-García RI, González-Romero C, Tamaríz-Mascarúa J, Morales-Rodríguez M, Zavala-Segovia N, Fuentes-Benítes A.. (2017) Synthesis and antifungal activity of novel oxazolidin-2-one-linked 1,2,3-triazole derivatives., 8 (12): [PMID:30108741] [10.1039/C7MD00442G] |
Source(1):